BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ELI LILLY AND COMPANY — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

ELI LILLY AND COMPANY

via VENN STRATEGIES

2nd Quarter (Apr 1 - June 30) · 2026Posted Jul 17, 2026Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: ELI LILLY AND COMPANY
Description: Pharmaceutical company
Location: District of Columbia · United States of America

Registrant

Firm: VENN STRATEGIES
Description: A political and public affairs consulting firm.
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
General Healthcare issues, including drug accessibility, importation and innovation policies.
LobbyistsMICHAEL SPIRA
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.